CVS Health Corp. stock underperforms Friday when compared to competitors
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with unparalleled accuracy. Back To Top
CVS Health Corp. (CVS): Among the Best Fortune 500 Stocks to Buy Now
We recently compiled a list of the 10 Best Fortune 500 Stocks To Buy Now. In this article, we are going to take a look at where CVS Health Corp. (NYSE:CVS) stands against the other Fortune 500 stocks.
CVS Health Corp (CVS) Stock: A Deeper Look at Its True Potential
CVS Health Corp (CVS) stock saw a modest uptick, ending the day at $58.42 which represents a slight increase of $0.59 or 1.02% from the prior close of $57.83. The stock opened at $57.88 and touched a low of $57.
CVS Health Corp. stock outperforms competitors on strong trading day
CVS Health Corp. closed $24.83 short of its 52-week high ($83.25), which the company reached on January 8th.
CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know
In the latest market close, CVS Health (CVS) reached $58.40, with a -0.03% movement compared to the previous day. The stock trailed the S&P 500, which registered a daily gain of 1.7%. Meanwhile, the Dow experienced a rise of 1.
The CVS Conundrum: Why CVS Health Corp’s Stock Is Making Headlines Again
CVS Health Corp (CVS) stock saw a decline, ending the day at $57.75 which represents a decrease of $-0.32 or -0.55% from the prior close of $58.07. The stock opened at $58.14 and touched a low of $57.
FTC Sues CVS, Cigna, UnitedHealth Over Rising Insulin Costs (1)
The US Federal Trade Commission sued units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. on Friday, accusing ...
Morningstar2d
CVS Health Corp
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Federal Trade Commission sues drug 'gatekeepers' over high insulin prices
The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.
Yahoo Finance2d
CVS Health Corporation (CVS)
CVS) Caremark, Cigna Corp’s (NYSE:CI) Express Scripts, and UnitedHealth Group Inc’s (NYSE:UNH) Optum—for allegedly engaging in unfair and anti-competitive practices that have inflated the ...
FTC sues drug middlemen over manipulating the insulin market
The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...
US Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth's Pharmacy Benefit Managers For Inflating Insulin Prices
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...
CVS Health announces quarterly dividend
CVS Health (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation. The ...
news.stocktradersdaily6d
(CVS) Technical Pivots with Risk Controls
Technical analysis for Cvs Health Corporation CVS including support levels resistance levels and stop losses for CVS ...